One rating per trading day the stock was covered.
Media highlighted the disconnect between Rocket Lab's falling share price and expanding backlog, alongside Ark Invest's aerospace buys.
Rocket Lab posted record Q3 revenue of $267.8M (up 73%), a 52% surge in backlog, and raised Neutron launch pricing to $70M ahead of its maiden flight.
Rocket Lab posted record Q3 revenue of $267.8M, up 73% and beating estimates, with record backlog. However, wider-than-expected GAAP losses and a broader space sector selloff led shares to fall 5%.
Rocket Lab's Q3 revenue rose 73% YoY to $268M beating estimates, with a record $3.57B backlog, though EPS loss was wider than expected and Neutron launch faced delays.
Rocket Lab reported record Q3 revenue but missed earnings estimates, prompting analyst price target cuts, with market focus shifting to Neutron development.
Rocket Lab surged 9% following NASA's $10B moon base contract awards and finished Neutron's first-stage forward dome ahead of Q3 earnings tonight.
Rocket Lab nears its 100th launch with steady sales growth, but analysts question whether valuation remains stretched following the Iridium deal after an 11x three-year rally.
Rocket Lab approaches Q3 earnings with a record backlog and surging revenue, yet shares are pressured by margin concerns, high valuation, and space sector drag from political scrutiny.
Rocket Lab reached a record backlog with surging revenue, and its spacecraft manufacturing division now generates four times launch revenue. Additionally, NASA cited Rocket Lab as a future launch option for commercial space stations, with its Neutron rocket targeted to debut in 2027.
Rocket Lab was highlighted by NASA as a key launch option for future commercial space stations via its Neutron rocket. Backlog stands at $2.36 billion, with space systems generating 4x launch revenue.
Stocktwits Space Race monthly roundup showed Rocket Lab trailing peers like Viasat in October performance, with no direct material corporate news released for the company.
The supplied news exclusively covers FTAI Aviation's Q3 earnings beat, with no direct operational or financial information regarding Rocket Lab.
Rocket Lab edged higher alongside global space technology peers, lifted by positive sector sentiment following SpaceX's blowout Q3 earnings beat.
Analysts flagged valuation risks for Rocket Lab at 52.6x sales, noting management's narrowing window to launch the Neutron rocket before the end of 2026.
Rocket Lab shares have fallen over 50% from highs amid dilution and earnings misses. Analysts note future profitability depends heavily on the unproven Neutron rocket.
Analysts reiterated bullish price targets for Rocket Lab despite recent pullbacks. Media coverage focused on its upcoming Neutron rocket launch and the recent approval of its Iridium acquisition.
Iridium shareholders overwhelmingly approved Rocket Lab's $8 billion acquisition of the company, setting Rocket Lab up to run one of the largest active satellite networks.
Rocket Lab shares surged 5%, rebounding from lows driven by sector takeover speculation, ARK Invest purchases, approval of its Iridium acquisition, and SpaceX's pullback from rideshares.
Iridium shareholders approved the acquisition by Rocket Lab in a $54-a-share deal, bringing the merger closer to completion. Additionally, Cathie Wood's ARK Invest purchased $25 million in Rocket Lab shares.
ARK Invest purchased $25 million worth of Rocket Lab stock on Tuesday as analysts praised revenue opportunities; the company is also readying for an upcoming mission.